Dr. Gulati is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Hospital Plz
Stamford, CT 06902Phone+1 203-276-2695Fax+1 203-975-7842
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 2011 - 2014
- University of Pennsylvania Health SystemResidency, Internal Medicine, 2008 - 2011
- Perelman School of Medicine at the University of PennsylvaniaClass of 2008
Certifications & Licensure
- NY State Medical License 2011 - 2026
- CT State Medical License 2014 - 2025
- PA State Medical License 2008 - 2012
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Prospective Phase I Study of GAX for Metastatic Pancreatic Cancer Start of enrollment: 2016 Feb 01
Publications & Presentations
PubMed
- 1214 citationsClinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.Nicole M. Kuderer, Toni K. Choueiri, Dimpy P. Shah, Yu Shyr, Samuel M. Rubinstein
Lancet. 2020-06-20 - 180 citationsCapecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience.Robert L. Fine, Anthony Paul Gulati, Benjamin A. Krantz, Rebecca A. Moss, Stephen M. Schreibman
Cancer Chemotherapy and Pharmacology. 2013-01-31 - 128 citationsAssociation of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19.Michael A. Thompson, Jeffrey P. Henderson, Pankil Shah, Samuel M. Rubinstein, Michael J. Joyner
JAMA Oncology. 2021-06-17
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: